ClinicalTrials.Veeva

Menu
N

New England Cancer Specialists | Topsham, ME

Research site
(Unclaimed)

Site insights

Top conditions

Top treatments

Sunitinib
Androgen
Avelumab
Axitinib
PF-06821497
Enfortumab
Abiraterone Acetate
Mevrometostat

Parent organization

This site is a part of New England Cancer Specialists

Curious how this site stacks up to its peers?

Data sourced from clinicaltrials.gov

Work at this site?

CTV for research professionals allows users to enhance their site’s profile, add contact information, and more.

Learn more and claim site

Active trials

1 of 4 total trials

A Study to Learn About the Investigational Medicine Called PF-06821497 (Mevrometostat) in Men With mCRPC Who Were Previously Treated With Abiraterone Acetate for Prostate Cancer (MEVPRO-1).

Pfizer MEVPRO-1 (C2321014) is a randomized, open-label, multi-center clinical trial evaluating whether combining the study medicine (PF-06821497) wit...

Enrolling
Metastatic Castrate Resistant Prostate Cancer (mCRPC)
Drug: PF-06821497
Drug: Enzalutamide

Trial sponsors

Pfizer logo
A
Astellas logo

Clinical trials

Find clinical trialsTrials by location
© Copyright 2025 Veeva Systems